Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07399080 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Outcomes of GENOSS PCB for Femoropopliteal Artery Disease

Study acronym: GENOSS PCB
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Secondary endpoints revised (9)v3 See this version in full on ClinicalTrials.gov ↗
  2. Secondary endpoints: details revised at 4 of 9 entriesv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The GENOSS PCB study aims to evaluate the safety and efficacy of a Paclitaxel-coated PTA Balloon Catheter(GENOSS® PCB) in patients with the femoropopliteal artery disease.
Trial Details
NCT Number NCT07399080
Lead Sponsor Genoss Co., Ltd.
Conditions PTA (Percutaneous Transluminal Angioplasty ), Femoropopliteal Artery Disease
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov